The study showed a reduction between 10% and 20% in lung failure, pneumonia, Alzheimers disease, lung failure, heart failure, and cardiac arrest among people who used GLP-1 drugs
Conflict of interest HX and SG was employed by company Changzhou Shanmei Pharmaceutical Research and Development Center Co., Ltd.The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
Rigorous and frequent blood glucose monitoring would be an absolute necessity in any research protocol
There were also improvements in blood pressure, fasting plasma glucose, and lipids in the treated group relative to the placebo
A key function of GLP-1 is to lower blood sugar levels, achieved through stimulating insulin production by the pancreas in response to high blood sugar, and inhibiting glucagon secretion, which otherwise raises blood sugar levels by promoting glucose production in the liver
Although candidacy for GLP-1 receptor agonists is high, penetration of use for MASH treatment remains suboptimal, one of the study authors, Zobair M
